meglumine has been researched along with Dysesthesia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbuti, D; Urso, S | 1 |
| Blumenfield, DM; Blumetti, RF; Goldstein, HA; Holyoak, WL; Hugo, FP; Kashanian, FK | 1 |
2 trial(s) available for meglumine and Dysesthesia
| Article | Year |
|---|---|
Lumbo-sacral radiculography with a new, water-soluble contrast medium: myelografin (meglumine ioserinate, SSH 239 AB).
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Contrast Media; Female; Headache; Humans; Iodobenzoates; Lumbar Vertebrae; Male; Meglumine; Middle Aged; Myelography; Myoclonus; Neuralgia; Paresthesia; Sacrum; Solubility; Spinal Nerve Roots; Triiodobenzoic Acids | 1979 |
Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Topics: Bilirubin; Clinical Trials as Topic; Contrast Media; Drug Combinations; Electrocardiography; Electroencephalography; Gadolinium; Gadolinium DTPA; Headache; Humans; Iron; Magnetic Resonance Imaging; Meglumine; Nausea; Organometallic Compounds; Paresthesia; Pentetic Acid; Research Design; Sorbitol; United States | 1990 |